SCHEMBL6340650

SCHEMBL6340650

COc1ccc(NS(=O)(=O)c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
HTT P42858 3/20 0.48
ALDH1A1 P00352 8/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
MAPK1 P28482 3/20 0.47
ALOX15 P16050 1/20 0.47
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
GAA P10253 2/20 0.43
WDR5 P61964 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PKM P14618 1/20 0.43
KDM4E B2RXH2 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2219490 0.82 SMN1; SMN2 (0.59) LMNASMN1; SMN2HTTALDH1A1KMT2A
SCHEMBL12429171 0.78 ALDH1A1 (0.52) LMNASMN1; SMN2HTTALDH1A1KMT2A
SCHEMBL5281126 0.77 SMN1; SMN2 (0.52) LMNASMN1; SMN2HTTALDH1A1KMT2A
SCHEMBL6118268 0.76 ALDH1A1 (0.56) LMNASMN1; SMN2HTTALDH1A1KMT2A
SCHEMBL31363722 0.76 MMP1 (0.52) LMNASMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL6350570 0.76 LMNA (0.60) LMNASMN1; SMN2HTTALDH1A1KMT2A
SCHEMBL6343513 0.76 LMNA (0.60) LMNASMN1; SMN2HTTALDH1A1KMT2A
SCHEMBL1186312 0.75 CA2 (0.54) LMNAALDH1A1KMT2AMMP1MMP2
SCHEMBL31173254 0.74 ALDH1A1 (0.54) SMN1; SMN2HTTALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL6351613 0.74 LMNA (0.58) LMNASMN1; SMN2HTTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187246-A1 Cell proliferation inhibitors LI QUN (US) 2005-08-25 US disclosed
US-6924304-B2 Cell proliferation inhibitors ABBOTT LABORATORIES (US) 2005-08-02 US disclosed
US-20030096856-A1 Cell proliferation inhibitors ABBVIE INC. 2003-05-22 US disclosed
US-6521658-B1 Cell proliferation inhibitors ABBOTT LABORATORIES 2003-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096856-A1 Cell proliferation inhibitors MKI67, CCNI, CCNA1 LMNA 1086/4885SMN1; SMN2 1869/4885HTT 4313/4885
US-20050187246-A1 Cell proliferation inhibitors MKI67, CCNI, CCNC LMNA 1211/4885SMN1; SMN2 2093/4885HTT 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.